![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 2 of 2. This is the beginning of the thread.
Posted by Rick on January 24, 2002, at 22:21:00
I dug this up for a different thread, but was intrigued by the Social Phobia apsect and thought it deserved its own thread (key sentence in CAPS).
Int J Clin Pract 2001 Oct;55(8):560-3
Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover.
Puri BK, Counsell SJ, Hamilton G, Richardson AJ, Horrobin DF.
MRI Unit, Imperial College School of Medicine, Hammersmith Hospital, London, W12 0HS, UK.
The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms. The niacin skin flush test and cerebral magnetic resonance scanning were carried out at baseline and nine months later. The addition of ethyl-EPA led to a dramatic and sustained clinical improvement in all the symptoms of depression, including a cessation of previously unremitting severe suicidal ideation, within one month. SYMPTOMS OF SOCIAL PHOBIA ALSO IMPROVED DRAMATICALLY. During the nine-month period the volumetric niacin response increased by 30%, the relative concentration of cerebral phosphomonesters increased by 53%, and the ratio of cerebral phosphomonesters to phosphodiesters increased by 79%, indicating reduced neuronal phospholipid turnover. Registered difference images showed that the EPA treatment was accompanied by structural brain changes including, in particular, a reduction in the lateral ventricular volume.
PMID: 11695079 [PubMed - indexed for MEDLINE]
Rick
Posted by janejj on January 25, 2002, at 11:12:47
In reply to Social Phobia: Fish Oil/Omega3 (EPA)????, posted by Rick on January 24, 2002, at 22:21:00
> I dug this up for a different thread, but was intrigued by the Social Phobia apsect and thought it deserved its own thread (key sentence in CAPS).
>
> Int J Clin Pract 2001 Oct;55(8):560-3
>
> Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover.
>
> Puri BK, Counsell SJ, Hamilton G, Richardson AJ, Horrobin DF.
>
> MRI Unit, Imperial College School of Medicine, Hammersmith Hospital, London, W12 0HS, UK.
>
> The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms. The niacin skin flush test and cerebral magnetic resonance scanning were carried out at baseline and nine months later. The addition of ethyl-EPA led to a dramatic and sustained clinical improvement in all the symptoms of depression, including a cessation of previously unremitting severe suicidal ideation, within one month. SYMPTOMS OF SOCIAL PHOBIA ALSO IMPROVED DRAMATICALLY. During the nine-month period the volumetric niacin response increased by 30%, the relative concentration of cerebral phosphomonesters increased by 53%, and the ratio of cerebral phosphomonesters to phosphodiesters increased by 79%, indicating reduced neuronal phospholipid turnover. Registered difference images showed that the EPA treatment was accompanied by structural brain changes including, in particular, a reduction in the lateral ventricular volume.
>
> PMID: 11695079 [PubMed - indexed for MEDLINE]
>
> Rick
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.